Exploring Patient Preferences for Reducing their RA Medications

New guidelines from the Canadian Rheumatology Association recommend rheumatologists include patients in decisions to reduce rheumatoid arthritis medications. The guidelines say that people with RA, in remission or low disease activity for at least six months, be offered the choice to reduce their biologic medications if they are able to quickly access rheumatology care and return to their original dose in case of a flare”.

We know your decision to reduce your RA medications will be influenced by many factors including any previous experience with treatment tapering, your current circumstances and goals.

The University of Calgary is conducting a survey to understand what factors make people living with rheumatoid arthritis more or less willing to reduce their medications.

If you are interested in participating in this research or for more information, please send an email to the project coordinator, Ann Rebutoc at rarebuto@ucalgary.ca.

If you are interested in contributing to this research, please click This Link to complete the survey.

Your responses will help us understand what factors are important to people who are considering reducing their medications.

This project has been approved by the University of Calgary Research Ethics Board: REB22-0460.

en_USEnglish
Powered by TranslatePress